Haokao Gao Selected Research

Haokao Gao Research Topics

Disease

17	Neoplasms (Cancer) 02/2013 - 01/2011
4	Reperfusion Injury 01/2014 - 08/2009
4	Breast Neoplasms (Breast Cancer) 01/2013 - 04/2011
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 04/2012
3	Insulinoma 03/2012 - 10/2011
2	Hemorrhage 01/2022 - 01/2022
2	Myocardial Ischemia (Ischemic Heart Diseases) 12/2012 - 01/2012
2	Prostatic Neoplasms (Prostate Cancer) 10/2012 - 01/2011
2	Pancreatic Neoplasms (Pancreatic Cancer) 07/2012 - 03/2012
2	Myocardial Infarction 04/2012 - 01/2012
2	Infarction (Infarctions) 01/2012 - 08/2009
1	Hypertension (High Blood Pressure) 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Hyperuricemia 01/2022
1	Stroke (Strokes) 01/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022
1	Hematoma 01/2022
1	Hypoxia (Hypoxemia) 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	Chronic Limb-Threatening Ischemia 12/2019
1	Ischemia 09/2015
1	Myocardial Reperfusion Injury 11/2014
1	Acute Coronary Syndrome 11/2014
1	Glioblastoma (Glioblastoma Multiforme) 02/2013
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2013
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 12/2012
1	Pathologic Neovascularization 01/2012
1	Heart Diseases (Heart Disease) 01/2012
1	Cardiac Arrhythmias (Arrythmia) 01/2012
1	Melanoma (Melanoma, Malignant) 10/2011
1	Head and Neck Neoplasms (Head and Neck Cancer) 10/2011
1	Bacterial Infections (Bacterial Infection) 02/2010
1	Atherosclerosis 02/2010

Drug/Important Bio-Agent (IBA)

4	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021 - 10/2011
4	Peptides (Polypeptides)IBA 12/2012 - 01/2011
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 04/2011
2	omega-Chloroacetophenone (Mace)IBA 12/2022 - 01/2022
2	Silicon Dioxide (Silica)FDA LinkGeneric 02/2013 - 06/2012
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2013 - 12/2012
2	liposomal doxorubicin (Doxil)FDA Link 01/2013 - 10/2011
2	Proteins (Proteins, Gene)FDA Link 12/2012 - 01/2012
2	IntegrinsIBA 12/2012 - 04/2012
2	AntibodiesIBA 07/2012 - 02/2010
2	AntigensIBA 07/2012 - 10/2011
2	Exenatide (Byetta)FDA Link 03/2012 - 01/2012
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	TicagrelorIBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Clopidogrel (Plavix)FDA Link 01/2022
1	ArrestinIBA 01/2021
1	MitoTEMPOIBA 12/2019
1	Small Interfering RNA (siRNA)IBA 09/2015
1	Complementary DNA (cDNA)IBA 09/2015
1	Rosuvastatin Calcium (Crestor)FDA Link 11/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2014
1	AnionsIBA 01/2014
1	Superoxides (Superoxide)IBA 01/2014
1	Superoxide DismutaseIBA 01/2014
1	Caspase 3 (Caspase-3)IBA 01/2013
1	Firefly LuciferasesIBA 01/2013
1	Peptide Receptors (Peptide Receptor)IBA 12/2012
1	Annexin A5IBA 12/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2012
1	LigandsIBA 10/2012
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 07/2012
1	Cell Adhesion MoleculesIBA 07/2012
1	Single-Domain AntibodiesIBA 07/2012
1	alfatide IIIBA 04/2012
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2012
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2012
1	antibiotic K 4 (K 4)IBA 01/2012
1	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 01/2012
1	LuteolinIBA 01/2012
1	Human Serum Albumin FDA LinkGeneric 10/2011
1	anthrax toxin (anthrax lethal factor)IBA 10/2011
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 07/2011
1	ZD 4190IBA 07/2011
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 07/2011
1	fluoromisonidazoleIBA 04/2011
1	Bombesin Receptors (Bombesin Receptor)IBA 01/2011
1	BombesinIBA 01/2011
1	oxidized low density lipoproteinIBA 02/2010
1	Immunoglobulin M (IgM)IBA 02/2010
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 08/2009
1	Glycogen Synthase (Synthase I)IBA 08/2009
1	Phosphatidylinositols (Phosphatidylinositol)IBA 08/2009
1	Glycogen Synthase Kinase 3 betaIBA 08/2009

Therapy/Procedure

8	Therapeutics 01/2022 - 04/2011
3	Percutaneous Coronary Intervention 01/2022 - 11/2014
3	Aftercare (After-Treatment) 01/2013 - 07/2011
1	Ligation 09/2015
1	Drug Therapy (Chemotherapy) 01/2013
1	Intravenous Injections 10/2011
1	Oral Administration 07/2011